- Home
- About
- Find staff
- Yvonne Arvidsson
Yvonne Arvidsson
Researcher
Department of Laboratory-
SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell
carcinoma
Oi Kuan Choong, Rasmus Jakobsson, Anna Grenabo Bergdahl, Sofia Brunet, Ambjörn Kärmander, Jesper Waldenström, Yvonne Arvidsson, Gülay Altiparmak, Jonas A Nilsson, Joakim Karlsson, Kristina Nyström, Martin E Johansson
Plos One - 2023 -
Exposure to nonanoic acid alters small intestinal neuroendocrine tumor
phenotype
Bilal Almobarak, Vishal Amlani, Linda Inge, Tobias Hofving, Andreas Muth, Ola Nilsson, Martin E Johansson, Yvonne Arvidsson, Erik Elias
BMC Cancer - 2023 -
SMAD4 haploinsufficiency in small intestinal neuroendocrine
tumors
Tobias Hofving, Erik Elias, Anna Rehammar, Linda Inge, Gülay Altiparmak, Marta Persson, Erik Kristiansson, Martin E Johansson, Ola Nilsson, Yvonne Arvidsson
BMC Cancer - 2021 -
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small
intestine.
Erik Elias, Arman Ardalan, Markus Lindberg, Susanne E Reinsbach, Andreas Muth, Ola Nilsson, Yvonne Arvidsson, Erik Larsson
Nature communications - 2021 -
177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90
inhibition
Tobias Hofving, Viktor Sandblom, Yvonne Arvidsson, Emman Shubbar, Gülay Altiparmak, John Swanpalmer, Bilal Almobarak, Anna-Karin Elf, Viktor Johanson, Erik Elias, Erik Kristiansson, Eva Forssell-Aronsson, Ola Nilsson
Endocrine-Related Cancer - 2019 -
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell
lines
Tobias Hofving, Yvonne Arvidsson, Bilal Almobarak, Linda Inge, R. Pfragner, Marta Persson, Göran Stenman, Erik Kristiansson, Viktor Johanson, Ola Nilsson
Endocrine-Related Cancer - 2018 -
miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient
survival
Yvonne Arvidsson, Anna Rehammar, Anders Bergström, Ellinor Andersson, Gülay Altiparmak, Christina Swärd, Bo Wängberg, Erik Kristiansson, Ola Nilsson
Modern Pathology - 2018 -
NAMPT inhibitor GMX1778 enhances the efficacy of 177Lu-DOTATATE treatment of neuroendocrine
tumors.
Anna-Karin Elf, Peter Bernhardt, Tobias Hofving, Yvonne Arvidsson, Eva Forssell-Aronsson, Bo Wängberg, Ola Nilsson, Viktor Johanson
Journal of Nuclear Medicine - 2017 -
Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor
GOT1.
Johanna Dalmo, Johan Spetz, Mikael Montelius, Britta Langen, Yvonne Arvidsson, Henrik Johansson, Toshima Z Parris, Khalil Helou, Bo Wängberg, Ola Nilsson, Maria Ljungberg, Eva Forssell-Aronsson
EJNMMI Research - 2017 -
Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour
Cells.
Yvonne Arvidsson, Viktor Johanson, Roswitha Pfragner, Bo Wängberg, Ola Nilsson
Neuroendocrinology - 2016 -
Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic
targets.
Ellinor Andersson, Yvonne Arvidsson, Christina Swärd, Tobias Hofving, Bo Wängberg, Erik Kristiansson, Ola Nilsson
Modern Pathology - 2016 -
Optimization of 177Lu-octreotate treatment of neuroendocrine
tumours
Eva Forssell-Aronsson, Johan Spetz, Britta Langen, Johanna Dalmo, Maria Larsson, Mikael Montelius, Nils Rudqvist, Toshima Z Parris, Yvonne Arvidsson, Maria Ljungberg, Khalil Helou, Ola Nilsson, Bo Wängberg
3rd Swedish Cancer Research Meeting, Stockholm, Sweden, September 2-3, 2014 - 2014 -
Priming administration before the main administration of 177Lu-octreotate increases the therapeutic effect in nude mice bearing human carcinoid tumor
GOT1
Johanna Dalmo, Johan Spetz, Mikael Montelius, Britta Langen, Yvonne Arvidsson, Henrik Johansson, Toshima Z Parris, Khalil Helou, Bo Wängberg, Ola Nilsson, Maria Ljungberg, Eva Forssell-Aronsson
27th Annual Congress on European Association of Nuclear Medicine, Gothenburg, Sweden, October 18-22, 2014 - 2014 -
Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin
analogs.
Gabriella Arne, Bengt E Nilsson, Johanna Dalmo, Erik Kristiansson, Yvonne Arvidsson, Eva Forssell-Aronsson, Ola Nilsson, Håkan Ahlman
Acta oncologica (Stockholm, Sweden) - 2013 -
New medical strategies for midgut
carcinoids.
Ola Nilsson, Yvonne Arvidsson, Viktor Johanson, Eva Forssell-Aronsson, Håkan Ahlman
Anti-cancer agents in medicinal chemistry - 2010 -
Hypoxia stimulates CXCR4 signalling in ileal
carcinoids.
Yvonne Arvidsson, Anders Bergström, Linda Arvidsson, Erik Kristiansson, Håkan Ahlman, Ola Nilsson
Endocrine-related cancer - 2010 -
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress
response
Mattias K Andersson, Anders Ståhlberg, Yvonne Arvidsson, Anita Olofsson, Henrik Semb, Göran Stenman, Ola Nilsson, Pierre Åman
BMC Cell Biology - 2008 -
Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal
tract.
Yvonne Arvidsson, Ellinor Andersson, Anders Bergström, Mattias K Andersson, Gülay Altiparmak, Ann-Christin Illerskog-Lindström, Håkan Ahlman, Darima Lamazhapova, Ola Nilsson
Endocrine-related cancer - 2008 -
A novel MASH1 enhancer with N-myc and CREB-binding sites is active in
neuroblastoma.
Fujiko Watt, Rie Watanabe, Weiwen Yang, N Ågren, Yvonne Arvidsson, Keiko Funa
Cancer gene therapy - 2007 -
Tissue and cell specific expression patterns of the proto-oncogenic FUS, EWS and TAF15
ribonucleoproteins
Mattias K Andersson, Yvonne Arvidsson, Anita Olofsson, Göran Stenman, Ola Nilsson, Pierre Åman
Molecular Targets for Cancer, Whistler Resort, Whistler, British Columbia, Canada - 2007 -
Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside
phosphorylase.
Yvonne Arvidsson, Venil Sumantran, Fujiko Watt, Hidetaka Uramoto, Keiko Funa
Pediatric blood & cancer - 2005 -
Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude
mice
Viktor Johanson, Yvonne Arvidsson, Lars Kölby, Peter Bernhardt, Christina Swärd, Ola Nilsson, Håkan Ahlman
Neuroendocrinology - 2005 -
ASK1 inhibits astroglial development via p38 mitogen-activated protein kinase and promotes neuronal differentiation in adult hippocampus-derived progenitor
cells.
Roland Faigle, Anke Brederlau, Muna Elmi, Yvonne Arvidsson, Tatsuo S Hamazaki, Hidetaka Uramoto, Keiko Funa
Molecular and cellular biology - 2004 -
Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on
proliferation.
Henrik Fagman, Fredrik Larsson, Yvonne Arvidsson, Johan Meuller, Margareta Nordling, Tommy Martinsson, Karen Helmbrecht, Georg Brabant, Mikael Nilsson
Oncogene - 2003 -
Gene therapy of
neuroblastoma
Yvonne Arvidsson
2003 -
ASK1 resistant neuroblastoma is deficient in activation of p38
kinase.
Yvonne Arvidsson, Tatsuo S Hamazaki, H Ichijo, Keiko Funa
Cell death and differentiation - 2001